Drug addiction is typically framed as a public health issue, a criminal justice issue, or a moral failing, depending on who is doing the framing.
What is rarely discussed is a resource allocation problem with a clearly better and worse solution. The data on this is not ambiguous. Incarceration costs more, produces worse outcomes, and generates higher long-term public expenditure than structured addiction treatment. Yet incarceration remains the default response in most jurisdictions.
For policymakers, investors interested in healthcare economics, and anyone tracking where government spending produces the poorest return, this gap between evidence and practice is worth understanding.
The Numbers Behind Incarceration
Incarcerating an individual in Australia costs between $110,000 and $130,000 per year, depending on the state and facility type.
A significant proportion of the prison population is there for drug-related offences, either possession and use, offences committed to fund drug dependence, or distribution charges. Estimates vary by jurisdiction, but drug-related crime consistently accounts for 40 to 60 percent of criminal convictions in Australian courts.
The recidivism rate among incarcerated individuals with untreated substance use disorders sits above 60 percent within two years of release. Without addressing the underlying dependence, the cycle of offending, arrest, prosecution, and incarceration repeats at full cost to the justice system each time.
The cumulative expenditure on a single individual who cycles through the justice system three or four times over a decade, without ever receiving effective treatment, runs into the hundreds of thousands of dollars in direct public cost alone.
What Treatment Actually Costs
(Source)
A residential addiction treatment programme in Australia typically costs between $8,000 and $30,000 for a 28 to 90-day stay depending on the facility, the level of clinical care provided, and whether medically assisted withdrawal is required.
Outpatient programmes, continuing care, and ongoing pharmacotherapy add to this figure over time but remain a fraction of the incarceration cost for equivalent periods.
A study by the Australian Institute of Health and Welfare found that every dollar invested in addiction treatment returns between four and seven dollars in reduced criminal justice costs, healthcare costs, and productivity gains. This is not a marginal improvement. It is a return profile that most publicly funded programmes would be considered highly successful for delivering.
The economic case for treatment over incarceration has been made consistently in health economics literature for decades. The challenge has never been the evidence. It has been political will and public perception.
The Productivity and Labour Market Cost of Untreated Addiction
Beyond justice system expenditure, untreated addiction imposes substantial costs on the labour market and on the families of those affected.
Opioid dependence, including heroin and prescription opioid misuse, significantly reduces workforce participation. Affected individuals cycle in and out of employment, accumulate debt, and frequently become dependent on welfare systems over extended periods.
The lost productivity cost of opioid addiction in Australia has been estimated in the billions of dollars annually when absenteeism, reduced work performance, and premature mortality are included in the calculation.
Family members of individuals with untreated addiction also bear disproportionate financial and psychological costs. Lost income from supporting a family member, legal costs, healthcare expenses, and the long-term economic impact on children raised in households affected by addiction all contribute to a broader economic burden that extends well beyond the individual.
Where Treatment Investment Produces the Greatest Return
Not all treatment investment is equally effective, and the evidence base on this is useful for anyone thinking about where public health dollars generate the strongest outcomes.
Residential rehabilitation for opioid dependence, particularly when combined with medically assisted withdrawal, structured therapeutic programming, and a planned aftercare pathway, consistently outperforms short-term detoxification alone on measures of sustained abstinence and reduced criminal activity.
For individuals in Victoria with heroin dependence, accessing specialist heroin rehabilitation services in Melbourne that combine clinical withdrawal management with evidence-based therapeutic support addresses both the physiological and behavioural dimensions of dependence.
This combination is associated with better long-term outcomes than either component delivered in isolation, which is where a significant proportion of underfunded public treatment systems fall short.
Opioid agonist therapy, including methadone and buprenorphine maintenance, is among the most cost-effective interventions in addiction medicine. It reduces illicit opioid use, significantly lowers overdose mortality, and keeps individuals engaged with healthcare systems and, where possible, the workforce. The cost per quality-adjusted life year saved through opioid agonist therapy compares favourably with most other medical interventions funded through public health systems.
The Political Economy of the Problem
The reason the evidence has not translated into a wholesale shift in policy is not a lack of data.
Incarceration is visible. A conviction, a sentence, and a prison term feel like accountability. Treatment is less legible to the public and politically harder to advocate for in environments where being seen as soft on crime carries electoral risk.
This creates a persistent gap between what the evidence supports and what the political incentives reward. The result is public systems that continue to allocate significantly more per capita to incarceration than to treatment, despite the documented return differential.
For healthcare investors and those tracking the social determinants of health as an investment theme, this gap represents both a systemic inefficiency and an opportunity. Governments that shift even a portion of justice spending toward treatment infrastructure generate measurable fiscal savings within years. The challenge is building the political consensus that makes that shift possible.
What a Rational Allocation Looks Like
A rational public investment strategy would redirect a defined proportion of criminal justice expenditure toward treatment infrastructure, with outcomes tracked against recidivism, welfare dependence, and workforce participation rather than conviction rates.
Several jurisdictions have piloted variations of this approach with positive results. Portugal's decriminalisation model, which redirected resources from prosecution toward treatment and social reintegration, is the most cited example internationally and produced measurable improvements across public health and economic indicators over a fifteen-year period.
The financial case is made. The implementation gap is a governance and political problem, not an evidence problem. For those who track where public money is spent poorly and where the return on reallocation is high, addiction treatment is one of the clearest examples available.
